Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

Millions of Americans use injectable drugs like Novo Nordisk’s Ozempic and Wegovy to help them lose weight - knowing there are possible side effects such as nausea, vomiting and diarrhea. Now, the U.S ...

The following is a press release written by Desiree DeMolina for the City of Bloomington. The City of Bloomington is aware of the announced workforce reduction at Novo and recognizes the impact this ...

Novo Holdings saw its assets shrink by a third last year as part of the fallout of Novo Nordisk’s nosediving share price. The Copenhagen-based firm, which is the controlling shareholder of Novo ...

Metsera said Novo Nordisk's new bid for the obesity biotech is "superior" to a revised offer from Pfizer, escalating a heated tussle over the startup between the two pharmaceutical giants. Novo ...

CHONGQING, CHINA - SEPTEMBER 10: In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. The maker of Wegovy and Ozempic, ...

Novo Nordisk was a leader in GLP-1 weight loss but was displaced by Eli Lilly. Investors have punished Novo Nordisk's stock, with the shares having lost more than half their value since mid-2024. Now ...

LONDON/COPENHAGEN, Oct 24 (Reuters) - A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, rattling investors despite calls for ...